It led to a drop in the production of programmed death ligand 1 (PD-L1), which not only enhanced the cytotoxic activity of T lymphocytes toward cancer cells but also resulted in a decline in viability and clonogenic potential of HeLa cells, and it correlated with reduced levels of c-myc and cyclin D1. The gene discussed is MYC; the disease is cancer.